Xarelto Bleeding – The Trials Go On

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Xarelto Bleeding – The Trials Go On

Despite a last ditch effort by the defendants to avoid another trip to court, Dora Mingo, who experienced a serious Xarelto bleeding event, will see her day in court.  

The Honorable Eldon E. Fallon,  Eastern District of Louisiana, ruled in favor of the plaintiffs last week denying a request for partial summary judgment by Janssen (a unit of Johnson & Johnson) and Bayer HealthCare Pharmaceuticals Inc.

Dora Mingo developed deep vein thrombosis (DVT) after having her hip replaced in 2015.  

She was given Xarelto to treat the DVT.  

Like many other individuals harmed by Xarelto, Mingo experienced uncontrollable bleeding that required hospitalization.  

Mingo’s lawsuit alleges that Janssen and Bayer knew of the Xarelto bleeding events likelihood and did not warn patients or doctors. 

There are more than 18,000 Xarelto bleeding lawsuits centralized in federal multidistrict litigation under the care of Judge Fallon in Lousiana.  

Mingo’s case is serving as the third bellwether trial, selected by the court to be fully prepared and tried by a jury.

Mingo’s case is designed to help move along possible settlements for other individuals injured by Xarelto in order to avoid clogging the courts with 18,000 cases with similar facts – use of a common product, Xarelto, and common defendant, Janssen and Bayer.    

xarelto bleeding trials

Mingo is the third plaintiff to go to trial.  

The two prior bellwether trials returned verdicts in favor of the defendants. 

Partial summary judgment is a procedural device that is used during civil litigation to promptly dispose of an entire case without a trial.  

It can be used either on the merits of the case or on discrete issues in the case.  

By rejecting the request for partial summary judgment, Judge Fallon is indicating that Mingo’s case has legal merit and decision on whether Xarelto caused her DVT will be left to a jury.

We look forward to keeping TruLaw followers and clients updated as to the result of the third Xarelto bellwether case. 

Table of Contents
Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources